2012 EORTC: SGI-110 enhances sorafenib activity and alters methylation signature of HCC Cell lines24 November 2012/in 2012, Guadecitabine (SGI-110) – (Hematological Malignancies and Solid Tumors), Products2012 EORTC: SGI-110 enhances sorafenib activity and alters methylation signature of HCC Cell lines https://astx.com/wp-content/uploads/2019/11/logo_white.png 0 0 webadmin https://astx.com/wp-content/uploads/2019/11/logo_white.png webadmin2012-11-24 16:38:092016-11-25 16:38:332012 EORTC: SGI-110 enhances sorafenib activity and alters methylation signature of HCC Cell lines
